← International Flavors & Fragrances overview

International Flavors & Fragrances vs Shin-Etsu Chemical Co.: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

International Flavors & Fragrances Inc (IFF)

Q3 2026
▲3▼1

IFF's big portfolio overhaul and buyback drive the story

  • IFF sells Food Ingredients for $3.8B and launches $2.5B buyback IFF agreed to sell its Food Ingredients unit to CVC for about $3.8 billion and announced a $2.5 billion share buyback, including a $500 million accelerated repurchase. This shrinks the company but sharpens focus on higher-margin Taste, Scent, and Health & Biosciences, and returning cash supports the stock.

    This is the biggest strategic event of the period, reshaping IFF's business and capital returns.

  • Q2 results miss and guidance cut on stranded costs IFF's Q2 revenue fell 29% to $1.95 billion and missed estimates badly, while full-year guidance was cut to $7.5 billion. Management blamed temporary stranded costs from the divestiture, but the miss and lower outlook weigh on investor confidence.

    The earnings miss and guidance cut are the main negative counterweight to the positive portfolio moves.

  • New product launches in scent and animal nutrition IFF launched SENSORA pro-fragrance technology, Omni-Bos PHY enzyme for dairy cattle, and AQUASCENT water-based fragrance carrier. These innovations target higher-margin growth areas and support the company's focus on R&D-led differentiation.

    Product launches show IFF's innovation pipeline and support future revenue growth.

  • Analysts and value funds see IFF as undervalued Morgan Stanley and Argus raised price targets, and Heartland Mid Cap Value Fund called IFF a deep-value opportunity trading at a discount to Givaudan. The new buyback and portfolio streamlining are seen as catalysts to close the valuation gap.

    This reflects external validation of IFF's turnaround story and potential upside.

August 2026
▲3▼1

IFF's big portfolio overhaul and buyback drive the story

  • IFF sells Food Ingredients for $3.8B and launches $2.5B buyback IFF agreed to sell its Food Ingredients unit to CVC for about $3.8 billion and announced a $2.5 billion share buyback, including a $500 million accelerated repurchase. This shrinks the company but sharpens focus on higher-margin Taste, Scent, and Health & Biosciences, and returning cash supports the stock.

    This is the biggest strategic event of the period, reshaping IFF's business and capital returns.

  • Q2 results miss and guidance cut on stranded costs IFF's Q2 revenue fell 29% to $1.95 billion and missed estimates badly, while full-year guidance was cut to $7.5 billion. Management blamed temporary stranded costs from the divestiture, but the miss and lower outlook weigh on investor confidence.

    The earnings miss and guidance cut are the main negative counterweight to the positive portfolio moves.

  • New product launches in scent and animal nutrition IFF launched SENSORA pro-fragrance technology, Omni-Bos PHY enzyme for dairy cattle, and AQUASCENT water-based fragrance carrier. These innovations target higher-margin growth areas and support the company's focus on R&D-led differentiation.

    Product launches show IFF's innovation pipeline and support future revenue growth.

  • Analysts and value funds see IFF as undervalued Morgan Stanley and Argus raised price targets, and Heartland Mid Cap Value Fund called IFF a deep-value opportunity trading at a discount to Givaudan. The new buyback and portfolio streamlining are seen as catalysts to close the valuation gap.

    This reflects external validation of IFF's turnaround story and potential upside.

Latest
▲3▼1

IFF's big portfolio overhaul and buyback drive the story

  • IFF sells Food Ingredients for $3.8B and launches $2.5B buyback IFF agreed to sell its Food Ingredients unit to CVC for about $3.8 billion and announced a $2.5 billion share buyback, including a $500 million accelerated repurchase. This shrinks the company but sharpens focus on higher-margin Taste, Scent, and Health & Biosciences, and returning cash supports the stock.

    This is the biggest strategic event of the period, reshaping IFF's business and capital returns.

  • Q2 results miss and guidance cut on stranded costs IFF's Q2 revenue fell 29% to $1.95 billion and missed estimates badly, while full-year guidance was cut to $7.5 billion. Management blamed temporary stranded costs from the divestiture, but the miss and lower outlook weigh on investor confidence.

    The earnings miss and guidance cut are the main negative counterweight to the positive portfolio moves.

  • New product launches in scent and animal nutrition IFF launched SENSORA pro-fragrance technology, Omni-Bos PHY enzyme for dairy cattle, and AQUASCENT water-based fragrance carrier. These innovations target higher-margin growth areas and support the company's focus on R&D-led differentiation.

    Product launches show IFF's innovation pipeline and support future revenue growth.

  • Analysts and value funds see IFF as undervalued Morgan Stanley and Argus raised price targets, and Heartland Mid Cap Value Fund called IFF a deep-value opportunity trading at a discount to Givaudan. The new buyback and portfolio streamlining are seen as catalysts to close the valuation gap.

    This reflects external validation of IFF's turnaround story and potential upside.

Shin-Etsu Chemical Co., Ltd. (4063.JP)

Q3 2026
▲2▼2

Shin-Etsu: AI demand and photoresist price hikes offset profit miss and China trade hit

  • NVIDIA deepens ties with Japanese suppliers, boosting wafer demand NVIDIA's CEO met with Shin-Etsu and other Japanese suppliers, signaling that AI expansion will keep driving demand for Shin-Etsu's silicon wafers. More AI chips mean more wafer sales, which supports future revenue and profits.

    This is a new demand signal that directly supports Shin-Etsu's core semiconductor materials business.

  • Full-year profit forecast misses market expectations, shares drop 8% Shin-Etsu projected net profit of 525 billion yen, below the 566.8 billion yen analysts expected. The weak outlook, partly from poor vinyl chloride conditions, caused the stock to fall over 8% as investors lowered their expectations.

    This is a new negative event that directly hit the stock price and reflects a real earnings shortfall.

  • Photoresist price hikes of up to 38% lift margins Shin-Etsu and peers are raising photoresist prices by 15% overall from October 1, with high-end grades up to 38% for spot orders. Higher prices should boost Shin-Etsu's revenue and profit margins in this key product line.

    This is a new pricing action that directly improves profitability for a major Shin-Etsu product.

  • China imposes up to 99.2% anti-dumping deposits on Shin-Etsu's dichlorosilane China will require deposits of up to 99.2% on imports of Shin-Etsu's dichlorosilane, a semiconductor material, starting September 8. This trade measure, seen as pressure on Japan, could hurt Shin-Etsu's sales to China and add uncertainty.

    This is a new regulatory/trade action that directly threatens Shin-Etsu's exports and adds a real counterweight.

August 2026
▲2▼2

Shin-Etsu: AI demand and photoresist price hikes offset profit miss and China trade hit

  • NVIDIA deepens ties with Japanese suppliers, boosting wafer demand NVIDIA's CEO met with Shin-Etsu and other Japanese suppliers, signaling that AI expansion will keep driving demand for Shin-Etsu's silicon wafers. More AI chips mean more wafer sales, which supports future revenue and profits.

    This is a new demand signal that directly supports Shin-Etsu's core semiconductor materials business.

  • Full-year profit forecast misses market expectations, shares drop 8% Shin-Etsu projected net profit of 525 billion yen, below the 566.8 billion yen analysts expected. The weak outlook, partly from poor vinyl chloride conditions, caused the stock to fall over 8% as investors lowered their expectations.

    This is a new negative event that directly hit the stock price and reflects a real earnings shortfall.

  • Photoresist price hikes of up to 38% lift margins Shin-Etsu and peers are raising photoresist prices by 15% overall from October 1, with high-end grades up to 38% for spot orders. Higher prices should boost Shin-Etsu's revenue and profit margins in this key product line.

    This is a new pricing action that directly improves profitability for a major Shin-Etsu product.

  • China imposes up to 99.2% anti-dumping deposits on Shin-Etsu's dichlorosilane China will require deposits of up to 99.2% on imports of Shin-Etsu's dichlorosilane, a semiconductor material, starting September 8. This trade measure, seen as pressure on Japan, could hurt Shin-Etsu's sales to China and add uncertainty.

    This is a new regulatory/trade action that directly threatens Shin-Etsu's exports and adds a real counterweight.

Latest
▲2▼2

Shin-Etsu: AI demand and photoresist price hikes offset profit miss and China trade hit

  • NVIDIA deepens ties with Japanese suppliers, boosting wafer demand NVIDIA's CEO met with Shin-Etsu and other Japanese suppliers, signaling that AI expansion will keep driving demand for Shin-Etsu's silicon wafers. More AI chips mean more wafer sales, which supports future revenue and profits.

    This is a new demand signal that directly supports Shin-Etsu's core semiconductor materials business.

  • Full-year profit forecast misses market expectations, shares drop 8% Shin-Etsu projected net profit of 525 billion yen, below the 566.8 billion yen analysts expected. The weak outlook, partly from poor vinyl chloride conditions, caused the stock to fall over 8% as investors lowered their expectations.

    This is a new negative event that directly hit the stock price and reflects a real earnings shortfall.

  • Photoresist price hikes of up to 38% lift margins Shin-Etsu and peers are raising photoresist prices by 15% overall from October 1, with high-end grades up to 38% for spot orders. Higher prices should boost Shin-Etsu's revenue and profit margins in this key product line.

    This is a new pricing action that directly improves profitability for a major Shin-Etsu product.

  • China imposes up to 99.2% anti-dumping deposits on Shin-Etsu's dichlorosilane China will require deposits of up to 99.2% on imports of Shin-Etsu's dichlorosilane, a semiconductor material, starting September 8. This trade measure, seen as pressure on Japan, could hurt Shin-Etsu's sales to China and add uncertainty.

    This is a new regulatory/trade action that directly threatens Shin-Etsu's exports and adds a real counterweight.